Ryan v. Gifford

918 A.2d 341, 40 Employee Benefits Cas. (BNA) 2907, 29 A.L.R. 6th 799, 2007 WL 416162, 2007 Del. Ch. LEXIS 22
CourtCourt of Chancery of Delaware
DecidedFebruary 6, 2007
DocketCivil Action 2213-N
StatusPublished
Cited by153 cases

This text of 918 A.2d 341 (Ryan v. Gifford) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ryan v. Gifford, 918 A.2d 341, 40 Employee Benefits Cas. (BNA) 2907, 29 A.L.R. 6th 799, 2007 WL 416162, 2007 Del. Ch. LEXIS 22 (Del. Ct. App. 2007).

Opinion

OPINION

CHANDLER, Chancellor.

On March 18, 2006, The Wall Street Journal sparked controversy throughout the investment community by publishing a one-page article, based on an academic’s statistical analysis of option grants, which revealed an arguably questionable compensation practice. Commonly known as backdating, this practice involves a company issuing stock options to an executive on one date while providing fraudulent documentation asserting that the options were actually issued earlier. These options may provide a windfall for executives because the falsely dated stock option grants often coincide with market lows. Such timing reduces the strike prices and inflates the value of stock options, thereby increasing management compensation. This practice allegedly violates any stock option plan that requires strike prices to be no less than the fair market value on the date on which the option is granted by the board. Further, this practice runs afoul of many state and federal common and statutory laws that prohibit dissemination of false and misleading information.

After the article appeared in the Journal, Merrill Lynch issued a report demonstrating that officers of numerous companies, including Maxim Integrated *346 Products, Inc., had benefited from so many fortuitously timed stock option grants that backdating seemed the only logical explanation. The report engendered this action.

Plaintiff Walter E. Ryan alleges that defendants breached their duties of due care and loyalty by approving or accepting .backdated options that violated the clear letter of the shareholder-approved Stock Option Plan and Stock Incentive Plan (“option plans”). Individual defendants move to stay this action in favor of earlier filed federal actions in California (“federal actions”). In the alternative, they move to dismiss this action on its merits.

In this Opinion, I grant individual defendants’ motion to dismiss all claims arising before April 11, 2001. I deny the remainder of the individual defendants’ motion to stay or dismiss.

I. FACTS

Maxim Integrated Products, Inc. is a technology leader in design, development, and manufacture of linear and mixed-signal integrated circuits used in microprocessor-based electronic equipment. From 1998 to mid-2002 Maxim’s board of directors and compensation committee granted stock options for the purchase of millions of shares of Maxim’s common stock to John F. Gifford, founder, chairman of the board, and chief executive officer, pursuant to shareholder-approved stock option plans filed with the Securities and Exchange Commission. Under the terms of these plans, Maxim contracted and represented that the exercise price of all stock options granted would be no less than the fair market value of the company’s common stock, measured by the publicly traded closing price for Maxim stock on the date of the grant. Additionally, the plan identified the board or a committee designated by the board as administrators of its terms.

Ryan is a shareholder of Maxim and has continuously held shares since his Dallas Semiconductor Incorporated shares were converted to Maxim shares upon Maxim’s acquisition of Dallas Semiconductor on April 11, 2001. He filed this derivative action on June 2, 2006, against Gifford; James Bergman, B. Kipling Hagopian, and A.R. Frank Wazzan, members of the board and compensation committee at all relevant times; Eric Karros, member of the board from 2000 to 2002, and M.D. Sam-pels, member of the board from 2001-2002. Ryan alleges that nine specific grants were backdated between 1998 and 2002, as these grants seem too fortuitously timed to be explained as simple coincidence. All nine grants were dated on unusually low (if not the lowest) trading days of the years in question, or on days immediately before sharp increases in the market price of the company.

A. Genesis of these Claims

As practices surrounding the timing of options grants for public companies began facing increased scrutiny in early 2006, Merrill Lynch conducted an analysis of the timing of stock option grants from 1997 to 2002 for the semiconductor and semiconductor equipment companies that comprise the Philadelphia Semiconductor Index. Merrill Lynch measured the aggressiveness of timing of option grants by examining the extent to which stock price performance subsequent to options pricing events diverges from stock price performance over a longer period of time. “Specifically, it looked at annualized stock price returns for the twenty day period subsequent to options pricing in comparison to stock price returns for the calendar year in *347 which the options were granted.” 1 In theory, companies should not generate systematic excess return in comparison to other investors as a result of the timing of options pricing events. “[I]f the timing of options grants is an arm’s length process, and companies have [not] systematically taken advantage of their ability to backdate options within the [twenty] day windows that the law provided prior to the implementation of Sarbanes Oxley in 2002, there shouldn’t be any difference between the two measures.” 2 Merrill Lynch failed to take a position on whether Maxim actually backdated; however, it noted that if backdating did not occur, management of Maxim was remarkably effective at timing options pricing events.

With regard to Maxim, Merrill Lynch found that the twenty-day return on option grants to management averaged 14% over the five-year period, an annualized return of 243%, or almost ten times higher than the 29% annualized market returns in the same period.

B. Similar Pending Actions

The Merrill Lynch report formed the bases for other derivative lawsuits. Robert McKinney filed a federal action in the Northern District of California on May 22, 2006, three weeks before this action was filed. Eugene Horkay, Jr. followed suit, filing an identical action in the same court two days later. The Northern District of California entered an order on June 14, 2006, consolidating these suits and all subsequently filed suits. Under this order, two more actions were consolidated. All four derivative plaintiffs have stipulated to consolidate and agreed to a lead plaintiff and lead counsel structure. Further, defendants and plaintiffs have entered into a stipulated scheduling order approved by that court. 3

The federal action is similar to the Delaware action. The federal plaintiffs posit claims of backdating based on the Merrill Lynch report. They specifically challenge ten option grants, alleging that backdating occurred. Further, they contend that this violation of their options plan exposes Maxim to adverse tax consequences.

The federal action differs in some respects, however. First, that action alleges that other officers, in addition to Gifford, benefited from backdated options. Further, the federal action names more director defendants. In addition to breach of fiduciary duty claims, the federal plaintiffs assert claims for aiding and abetting breach of fiduciary duty, abuse of control, gross mismanagement, constructive fraud and corporate waste.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Petit v. Tri-State Wholesale Flooring, LLCO
Superior Court of Delaware, 2023
Parseghian v. Frequency Therapeutics, Inc.
Superior Court of Delaware, 2023
Timothy J. Harris v. Mary Ellen Harris
Court of Chancery of Delaware, 2023
Lebanon County Employees' Retirement Fund v. Collis
Court of Chancery of Delaware, 2022
In Re: Match Group Inc. Derivative Litigation
Court of Chancery of Delaware, 2022
MKE Holdings LTD v. Kevin Schwartz
Court of Chancery of Delaware, 2020
In Re LendingClub Corp. Derivative Litigation
Court of Chancery of Delaware, 2019
In re Clovis Oncology, Inc. Derivative Litigation
Court of Chancery of Delaware, 2019
Donald Reith v. Warren G. Lichtenstein
Court of Chancery of Delaware, 2019
U.S. Small Bus. Admin. Funding Corp. v. Feinsod
347 F. Supp. 3d 147 (E.D. New York, 2018)
Hall v. Maritek Corporation
Supreme Court of Delaware, 2018
H&N Managment Group, Inc. v. Robert M. Couch
Court of Chancery of Delaware, 2017
Jan Donnawell v. Daniel Hamburger
803 F.3d 912 (Seventh Circuit, 2015)
Jeffrey Kaufman v. Barbara T. Alexander
625 F. App'x 129 (Third Circuit, 2015)
Teamsters Union 25 Health Services & Insurance Plan v. Gavin Baiera
119 A.3d 44 (Court of Chancery of Delaware, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
918 A.2d 341, 40 Employee Benefits Cas. (BNA) 2907, 29 A.L.R. 6th 799, 2007 WL 416162, 2007 Del. Ch. LEXIS 22, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ryan-v-gifford-delch-2007.